Lanean...
Chronic Subcutaneous BNP Therapy in Asymptomatic Systolic Heart Failure
AIM: We have previously reported that asymptomatic systolic heart failure (HF) is characterized by an impaired renal response to volume expansion due to lack of activation of urinary cGMP which is corrected by subcutaneous B-type natriuretic peptide (BNP). In the current study we sought to define th...
Gorde:
| Argitaratua izan da: | Eur J Heart Fail |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4874857/ https://ncbi.nlm.nih.gov/pubmed/26806605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.468 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|